Caraco Pharmaceutical Laboratories Announces Successful Tender Offer To Acquire DUSA

   Caraco Pharmaceutical Laboratories Announces Successful Tender Offer To
                                 Acquire DUSA

PR Newswire

DETROIT, Dec. 20, 2012

DETROIT, Dec.20, 2012 /PRNewswire/ --Caraco Pharmaceutical Laboratories,
Ltd. ("CPL"), a subsidiary of Sun Pharmaceutical Industries Limited ("Sun
Pharma"), today announced that in connection with the previously announced
merger agreement, the tender offer by Caraco Acquisition Corporation, a
wholly-owned subsidiary of CPL, to acquire all of the outstanding shares of
common stock of DUSA Pharmaceuticals, Inc. (NASDAQ GM: DUSA) ("DUSA") for
$8.00 per share, net to the seller thereof in cash, without interest thereon
and less any applicable withholding taxes, expired at 12:00 Midnight, New York
City time, on December 19, 2012 (at the end of the day on December 19, 2012).
All shares that were validly tendered into the offer and not properly
withdrawn will be accepted for payment and paid promptly in accordance with
the terms of the offer.

The depositary for the tender offer has advised that, as of the offer's
expiration, 20,946,624 shares of common stock of DUSA (excluding approximately
1,035,094 shares subject to guarantees of delivery) had been validly tendered
and not properly withdrawn pursuant to the tender offer, which represents
approximately 82.4% of the outstanding shares of DUSA.

CPL intends to promptly move forward with a "short-form" merger under New
Jersey law after exercising its top-up option under the merger agreement, and
DUSA will become a wholly owned subsidiary of CPL.The merger is expected to
be completed on or about December 20, 2012.As a result of the merger, any
shares of DUSA common stock (except for shares held by (i) DUSA as treasury
stock or (ii) Sun Pharma, CPL or their direct or indirect subsidiaries) not
previously tendered, will be cancelled and shall cease to exist and will be
converted into the right to receive the same $8.00 per share in cash paid in
the tender offer. Following the merger, DUSA's common stock will cease to be
traded on The NASDAQ Global Market.

About Caraco Pharmaceutical Laboratories

Detroit-based Caraco Pharmaceutical Laboratories, Ltd. develops, manufactures,
markets and distributes generic pharmaceuticals to the nation's largest
wholesalers, distributors, drugstore chains and managed care providers.

SOURCE Caraco Pharmaceutical Laboratories, Ltd.

Contact: Thomas Versosky, Sr. Director of Business Strategies, +1-313-556-4150
Press spacebar to pause and continue. Press esc to stop.